Innate and Adaptive Immune Responses in Intestinal Transplant Rejection: Through the Lens of Inflammatory Bowel and Intestinal Graft-Versus-Host Diseases

lymphoid cells (ILC)1s and the regulatory interleukin IL-22 from ILC3s plays a critical role in modulating the immune response in intestinal transplant. Furthermore, natural killer cells may contribute to either rejection or tolerance in intestinal transplant via the acti. For adaptive immunity, intestinal transplantation rejection is primarily driven by proinflam. Elevated ILC1/ILC3 and Th17/Treg population ratios and the plasticity of these cell types